Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Site search
Search
Toggle navigation
Contact Us
Subscribe
Promote Your Event
e-Edition
Privacy Policy
Terms of Service
Local Weather
Home Delivery
Submission Forms
News
Local News
The Leader
Heartland News
Sports
Entertainment
Local Events
Multimedia
Photo Galleries
Videos
Obituaries
Classifieds
Real Estate
Property for Rent
Cars & Vehicles
Jobs
Items for Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place an ad
Legals
Best of 2022
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Adagene Inc ADR
(NQ:
ADAG
)
1.554
UNCHANGED
Streaming Delayed Price
Updated: 2:46 PM EDT, Mar 20, 2023
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
0
Open
1.554
Bid (Size)
1.340 (37)
Ask (Size)
1.620 (3)
Prev. Close
1.554
Today's Range
1.554 - 1.554
52wk Range
0.9000 - 4.800
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
Top News
More News
Adagene Announces Poster Presentations on Anti-CTLA-4 SAFEbody®, ADG126, at Upcoming American Association for Cancer Research (AACR) Annual Meeting in April
March 14, 2023
From
Adagene Inc.
Via
Globe NewsWire
Adagene Appoints Professor Aurélien Marabelle to Scientific and Strategic Advisory Board
March 05, 2023
From
Adagene Inc.
Via
Globe NewsWire
Performance
YTD
+22.35%
+22.35%
1 Month
-9.66%
-9.66%
3 Month
+13.42%
+13.42%
6 Month
+7.90%
+7.90%
1 Year
-66.30%
-66.30%
More News
Read More
Adagene Announces Interim Data Demonstrating Safety and Confirmed Clinical Responses of Anti-CTLA-4 SAFEbody® ADG126 up to 10 mg/kg with Repeat Cycles in Combination with Anti-PD-1 Therapy from Dose Escalation Portion of Phase 1b/2 Trial
January 09, 2023
From
Adagene Inc.
Via
Globe NewsWire
Adagene to Present at the Biotech Showcase™ 2023 in San Francisco on January 9
January 05, 2023
From
Adagene Inc.
Via
Globe NewsWire
12 Health Care Stocks Moving In Thursday's Pre-Market Session
December 22, 2022
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
December 22, 2022
Via
InvestorPlace
12 Health Care Stocks Moving In Friday's Pre-Market Session
December 16, 2022
Via
Benzinga
Why Avaya Holdings Shares Are Trading Lower By 62%? Here Are 62 Stocks Moving In Friday's Mid-Day Session
December 16, 2022
Via
Benzinga
Adagene Announces Clinical Trial Collaboration to Evaluate Anti-CTLA-4 SAFEbody® ADG126 in Combination with Roche’s Standard-of-Care for First-Line Advanced Liver Cancer
December 16, 2022
From
Adagene Inc.
Via
Globe NewsWire
Adagene Appoints Cuong Do to Board of Directors and Audit Committee
November 21, 2022
From
Adagene Inc.
Via
Globe NewsWire
Adagene Announces Clinical Data at SITC 2022 on Anti-CTLA-4 NEObody™, ADG116, Showing Differentiated Safety and Anti-tumor Activity in Heavily Pre-treated Patients with Difficult-to-Treat Tumors
November 10, 2022
From
Adagene Inc.
Via
Globe NewsWire
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
November 01, 2022
Via
InvestorPlace
Stocks That Hit 52-Week Lows On Tuesday
October 25, 2022
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
October 25, 2022
Via
Benzinga
Adagene Announces Poster Presentations on Anti-CTLA-4 NEObody™, ADG116, at Upcoming Society for Immunotherapy of Cancer’s (SITC) Annual Meeting in November
October 11, 2022
From
Adagene Inc.
Via
Globe NewsWire
The Daily Biotech Pulse: Pfizer/BioNTech Ink New COVID-19 Vaccine Supply Pact, Sanofi Hit By FDA Clinical Hold, Angion Biomedica Halts Second Kidney Disease Trial
June 30, 2022
Via
Benzinga
Aspen Aerogels And 28 Stocks Moving Premarket
June 30, 2022
Via
Benzinga
Stocks That Hit 52-Week Lows On Tuesday
August 02, 2022
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
June 29, 2022
Via
Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
June 17, 2022
Via
Benzinga
Why Is NeuroSense Therapeutics Jumping By 45%? 64 Stocks Moving In Thursday's Mid-Day Session
June 30, 2022
Via
Benzinga
Adagene Shares Pop After FDA Clears Phase 1b/2 Trial For ADG126/Keytruda Combo Therapy In Solid Tumors
March 16, 2022
Via
Benzinga
71 Biggest Movers From Yesterday
June 16, 2022
Via
Benzinga
HFCAA News: 128 Chinese Stocks the SEC Could Delist
May 05, 2022
Via
InvestorPlace
Stocks That Hit 52-Week Lows On Thursday
March 31, 2022
Via
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.